Pharmacometrics Archives

Case Study

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix Hosted

Discover how Certara's Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing…

CertaraMay 31, 2024

On-Demand Webinar

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies

Targeted radiation therapies (TRT) deliver cytotoxic radiation selectively to tumors. In recent years, oncology drug…

CertaraMay 22, 2024

On-Demand Webinar

What is new in Phoenix 8.5?

Discover the latest advancements and enhancements in Phoenix version 8.5. Watch the webinar to learn…

CertaraFebruary 26, 2024

On-Demand Webinar

Streamlining Your NCA Workflow

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…

CertaraJanuary 18, 2024

On-Demand Webinar

Bridging the Gap: Integrating Pharmacometrics with Quantitative Systems Pharmacology (QSP) for Smoother Clinical Phase Transitions

Master clinical phase transitions with insights from industry leaders! Join Piet van der Graaf, SVP…

CertaraJanuary 2, 2024

Press Coverage

Modeling and simulation in pediatric drug development

Published: December 21, 2023 This is the article written in German, published on pharmind. Children's…

CertaraDecember 21, 2023

Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Case Study

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…

CertaraMay 9, 2023

Case Study

Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer

Bispecific antibodies are an emerging class of antibodies developed in recent years that provide new…

CertaraJanuary 23, 2023

Case Study

Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another

Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare genetic disease that causes abnormal blood clot…

CertaraJune 1, 2022

Pharmacometrics

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix Hosted

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies

What is new in Phoenix 8.5?

Streamlining Your NCA Workflow

Bridging the Gap: Integrating Pharmacometrics with Quantitative Systems Pharmacology (QSP) for Smoother Clinical Phase Transitions

Modeling and simulation in pediatric drug development

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer

Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another

Newsletter sign up

Quick links

Solutions

Contact